BEAM Competitors & Alternatives
Compare Beam Therapeutics Inc with similar stocks in the same industry
Biotechnology
BEAM
Main Stock$25.52
Tradestie Score
48
Market Cap
$2.44B
Revenue Growth
3.2%
Analyst Upside
+105.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$62.67
|
$3.02B | - | 53 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$71.19
|
$3.01B | - | 52 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$24.91
|
$2.89B | - | 57 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$38.62
|
$2.85B | - | 51 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 59 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$59.04
|
$2.42B | - | 46 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$158.61
|
$2.41B | - | 51 | Compare |
More BEAM Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry